Overview
Work History
Education
Skills
Congresses
Complementary Education
Languages
Languages
Timeline
Generic
Esther Mairal Sallán

Esther Mairal Sallán

Barcelona

Overview

22
22
years of professional experience

Work History

Medical Manager

Grifols S.A. Laboratories
04.2019 - 12.2022
  • Global position EU and Rest of the World (ROW)
  • Coagulation Area
  • Hemophilia A and von Willebrand Disease
  • Products: Fanhdi Alphanate (Factor VIII and von Willebrand Factor)
  • Tasks: Scientific expert of the coagulation portfolio, business support for EU and ROW countries
  • Medical plan strategy in collaboration with Marketing and Market access departments
  • Scientific update for internal customers -sales teams, marketing-, external customers: on-line continuing medical education, scientific symposia for both local and international scientific societies, train the trainer's sessions (von Willebrand disease)
  • Collaboration with the Clinical Research department (follow up of the investigational clinical trials, ongoing trials and to initiate)
  • Design and implementation of post-authorization studies in von Willebrand Disease, Hemophilia A and ITI
  • Support to Marketing Department in generation of promotional materials: review of claims and all statements of the scientific content following the standards of compliance in Pharmaceutical Industry
  • Collaboration with the Business Development department for exploring new business proposals in hematology.

Medical Manager

ESTEVE Laboratories
03.2015 - 12.2018
  • Cardiovascular Therapeutic Area: Hypercholesterolemia: Alipza (pitavastatin)
  • Hypertension: Dafiro HCT , valsartan family (valsartan, amlodipine and hydrochlorothiazide)
  • Oral direct anticoagulants: launch of dabigatran (Pradaxa , co-promotion with Boehringer-Ingelheim)
  • Tasks: Being the scientific reference on the cardiovascular therapeutic area for both internal and external stakeholders and customers
  • Implementation of the Tactical Medical Plan following the Strategic Brand Plan of the therapeutic area products: KOL engagement plan, visory boards) medical training -sales representatives and MSL- medical training of the external costumer –primary care, specialists-, close collaboration with Market Access (delphi studies, pharmacoeconomic study), post-authorization studies design and follow up.)
  • Review of promotional materials.

Medical Advisor

MENARINI Laboratories
01.2010 - 01.2014
  • Sexual Medicine Area
  • From 2012 to 2014
  • Launch of a drug for premature ejaculation (Priligy or dapoxetine) April, 2013
  • Launch of a drug for erectile dysfunction (Spedra or avanafil), May 2014
  • Tasks: active search of new KOL (new business unit)
  • Leading Advisory Boards to determine the strategic medical plan pre and post-lunch of each portfolio product (studies, medical activities
  • Becoming the scientific reference for the follow-up of the strategic medical plan and development of new scientific proposals (protocols of clinical or epidemiological studies, training courses, etc.)

Medical Advisor

SOLVAY PHARMA (now AbbVie since 2010)
01.2006 - 01.2010
  • Central Nervous System
  • Duodopa (levodopa and carbidopa intraduodenal administration)
  • Drug for hospital use
  • Indicated for the treatment of advanced Parkinson's disease
  • Main task, preparation of scientific documentation for its approval in hospital pharmacy services and presentations in neurology services
  • Mature Products
  • Urology: Pronitol or Pygium Africanum (symptomatic treatment of benign prostatic hyperplasia)
  • Digestive: Duphalac (lactulose), lipid-lowering drugs: Digaril Prolib (fluvastatin), antivertiginous drug: Serc (betahistine), Influvac: Flu Vaccine
  • Tasks: Medical Marketing activities: preparation of promotional materials, scientific training medical representatives
  • Clinical research activities: following of the multicenter phase III studies at the local level (parkinson's disease, schizofrenia: antipsychotics, etc), of post-authorization studies (Parkinson's disease), quality of life studies (intestinal constipation).

Drug Safety Manager and Responsible of Good Clinical Practices (GCP)

SALVAT, S.A. Laboratories
01.2005 - 01.2006
  • All the tasks involved in Pharmacovigilance
  • Quality assurance of GCP in clinical trials (phase I, II and III).

Medical Advisor

NOVARTIS
01.2004 - 01.2005
  • Cardiovascular products: Codiovan 160 / 12.5 (valsartan 160 mg and hydrochlorothiazide 12.5 mg)
  • Scientific support for its launch
  • Diovan (valsartan)
  • Metabolism products: Lescol Prolib (fluvastatin)
  • Tasks: Preparation of scientific documentation: scientific literature searches, updates of monographies
  • Review of promotional materials
  • Scientific training of medical representatives (primary care and specialists).

Specialization, training in Clinical Pharmacology

Hospital de la Santa Creu i Sant Pau
Barcelona
01.2001 - 01.2004
  • Phase I Clinical Trials: bioequivalence studies to obtain the registry of generic pharmaceutical specialties from national and multinational laboratories
  • Assistance to the monthly meetings of the Clinical Research Ethics Committee of the hospital
  • Collaborator as Medical Writer for Prous Science Editorial
  • Functions: medical writing of briefings of clinical trials for including in a database.

Medical Affairs Manager

CSL Behring
01.2023
  • Medical Affairs Manager of Hematology and Thrombosis
  • Spain and Portugal
  • Coagulation portfolio and investigational products: hematology and cardiovascular area
  • Hemophilia A, B, von Willebrand and Critical Bleeding
  • Products: Pre-launch of gene therapy, Hemgenix, Afstyla, Idelvion, Haemate P, Riastap and the corresponding brands in Portugal
  • Tasks: Scientific expert reference for Gene therapy in hemophilia B, Hemgenix
  • Responsible for the Coagulation portfolio strategic and tactical medical plan: generation and review of the Tactical Medical Plan in collaboration with Marketing and Market access departments
  • Advisory Boards for gene therapy, von Willebrand disease
  • Continuous medical education: external (HCP), organization of scientific symposia, train the trainers
  • Internal training: regional medical engagement specialists, sales reps, regional market access
  • Support to Regulatory Affairs, Pharmacovigilance and Medical Information
  • Medical Affairs Manager of the hematology Team
  • Team management of 3 Regional Medical Engagement Specialists reporters, new role of MSLs (4 in the coming months).

Education

Degree in Medicine and Surgery -

University of Barcelona
01.2001

Postgraduate "Medicine of the Pharmaceutical Industry" -

Autonomous University of Barcelona

Skills

  • Windows environment and Microsoft Office
  • Clinical Leadership
  • Patient care management
  • Risk Management
  • Decision-Making
  • Critical Thinking
  • Budget Development
  • Interdepartmental Functions Coordination
  • Employee Training Program
  • Team building
  • Continuous Improvement
  • Time Management

Congresses

  • ISTH congress 2019 to 2021
  • EAHAD congress 2019 -2024
  • EHA congress 2019 to 2021
  • SEHH and SETH Spanish congress, 2019 to 2023
  • European Society of Cardiology 2015 London and 2017 Barcelona
  • National Congresses Spanish Society of Cardiology (SEC, Clinical Cardiology Section)
  • European Society of Atherosclerosis 2015, Glasgow
  • National congresses of national atherosclerosis 2015 La Rioja, 2016 Granada and 2017 Cádiz
  • European congresses of the European Urology Association Stockholm 2014 and Milan, 2013
  • International Sexual Society of Medicine, Amsterdam 2012 and Istanbul 2014
  • National urology congresses of the Spanish Association of Urology, in Granada, 2013 and in Tenerife, 2014
  • Congresses and courses of the Puigvert Foundation
  • Spanish Association of Ambulatory Surgery, Oviedo 2011
  • The European Society of Regional Anesthesia, ESRA-Spain, Barcelona 2011
  • Spanish Pain Society Congress, May 2010
  • Movement Disorders Society Congress, Istanbul, June 2007
  • Spanish Society of Neurology, November 2006
  • United European Gastro Week, Stockholm, October 2011
  • International Headache Society, Berlin, June 2011
  • Spanish Society of Rheumatology Congress, May 2010
  • National Medicine Congresses of Primary Care: SEMERGEN Society, from 2015 to 2017, SEMG Society from 2015 to 2017
  • AMIFE Congress. Association of Medicine of the Pharmaceutical Industry, November 2009 and 2014
  • Pharmacogenetics Conference. Hospital of Sant Pau. 5 hours, January 2003
  • XVIII National Congress of the Spanish Society of Clinical Pharmacology, October 17-19, 2002, Navarra
  • Conference "Medical Doctors, Clinical Research and Pharmaceutical Industry" at Official College of Medical Doctors of Barcelona (C.O.M.B.) November 30, 2001
  • XVII National Congress of the Spanish Society of Clinical Pharmacology, from November 22 to 24, 2001, Sevilla

Complementary Education

  • Seminars for doctoral thesis, Department of Pharmacology, Therapeutics and Toxicology, Autonomous University of Barcelona, 2001-2002
  • Training in the Clinical Pharmacology Department, Hospital de la Santa Creu i Sant Pau, 2001-2004
  • Training in Pharmacovigilance, Various institutions, 2005

Languages

Fluent, Fluent, Advanced

Languages

Spanish
First Language
English
Advanced (C1)
C1
Catalan
Proficient (C2)
C2

Timeline

Medical Affairs Manager

CSL Behring
01.2023

Medical Manager

Grifols S.A. Laboratories
04.2019 - 12.2022

Medical Manager

ESTEVE Laboratories
03.2015 - 12.2018

Medical Advisor

MENARINI Laboratories
01.2010 - 01.2014

Medical Advisor

SOLVAY PHARMA (now AbbVie since 2010)
01.2006 - 01.2010

Drug Safety Manager and Responsible of Good Clinical Practices (GCP)

SALVAT, S.A. Laboratories
01.2005 - 01.2006

Medical Advisor

NOVARTIS
01.2004 - 01.2005

Specialization, training in Clinical Pharmacology

Hospital de la Santa Creu i Sant Pau
01.2001 - 01.2004

Degree in Medicine and Surgery -

University of Barcelona

Postgraduate "Medicine of the Pharmaceutical Industry" -

Autonomous University of Barcelona
Esther Mairal Sallán